XENETIC BIOSCIENCES, INC. Earnings Per Share, Basic and Diluted
XENETIC BIOSCIENCES, INC. (XBIO) reported Earnings Per Share, Basic and Diluted of -$0.55 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-22.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-22
- XENETIC BIOSCIENCES, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.13.
- XENETIC BIOSCIENCES, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.13.
- XENETIC BIOSCIENCES, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.15.
- XENETIC BIOSCIENCES, INC. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.18.
- XENETIC BIOSCIENCES, INC. earnings per share, basic and diluted for fiscal 2021 was -$0.55.
- XENETIC BIOSCIENCES, INC. earnings per share, basic and diluted for fiscal 2020 was -$1.70.
- XENETIC BIOSCIENCES, INC. earnings per share, basic and diluted for fiscal 2019 was -$6.33.
- XENETIC BIOSCIENCES, INC. earnings per share, basic and diluted for fiscal 2018 was -$9.66.
| Period end | Earnings Per Share, Basic and Diluted 1 month | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | -$0.55 10-K · filed 2022-03-22 | ||||||||
| 2021-09-30 | -$0.13 10-Q · filed 2021-11-12 | -$0.41 10-Q · filed 2021-11-12 | |||||||
| 2021-06-30 | -$0.13 10-Q · filed 2021-08-12 | -$0.28 10-Q · filed 2021-08-12 | |||||||
| 2021-03-31 | -$0.15 10-Q · filed 2021-05-11 | ||||||||
| 2020-12-31 | -$0.18 derived: net income ÷ weighted average shares · filed 2022-03-22 | -$1.34 derived: net income ÷ weighted average shares · filed 2022-03-22 | -$1.51 derived: net income ÷ weighted average shares · filed 2022-03-22 | -$1.70 10-K · filed 2022-03-22 | |||||
| 2020-09-30 | -$1.20 10-Q · filed 2021-11-12 | -$1.35 derived: net income ÷ weighted average shares · filed 2021-11-12 | -$1.55 10-Q · filed 2021-11-12 | -$1.76 derived: net income ÷ weighted average shares · filed 2021-11-12 | |||||
| 2020-06-30 | -$0.15 10-Q · filed 2021-08-12 | -$0.34 10-Q · filed 2021-08-12 | -$0.54 derived: net income ÷ weighted average shares · filed 2021-08-12 | -$2.45 derived: net income ÷ weighted average shares · filed 2021-08-12 | |||||
| 2020-03-31 | -$0.19 10-Q · filed 2021-05-11 | -$0.39 derived: net income ÷ weighted average shares · filed 2021-05-11 | -$2.38 derived: net income ÷ weighted average shares · filed 2021-05-11 | -$3.34 derived: net income ÷ weighted average shares · filed 2021-05-11 | |||||
| 2019-12-31 | -$0.20 derived: net income ÷ weighted average shares · filed 2021-03-16 | -$2.37 derived: net income ÷ weighted average shares · filed 2021-03-16 | -$3.65 derived: net income ÷ weighted average shares · filed 2021-03-16 | -$6.33 10-K · filed 2021-03-16 | |||||
| 2019-09-30 | -$2.67 10-Q · filed 2020-11-12 | -$4.92 derived: net income ÷ weighted average shares · filed 2020-11-12 | -$9.07 10-Q · filed 2020-11-12 | -$11.70 derived: net income ÷ weighted average shares · filed 2020-11-12 | |||||
| 2019-06-30 | -$1.56 10-Q · filed 2020-08-12 | -$7.79 10-Q · filed 2020-08-12 | -$9.97 derived: net income ÷ weighted average shares · filed 2020-08-12 | -$12.32 derived: net income ÷ weighted average shares · filed 2020-08-12 | |||||
| 2019-03-31 | -$6.45 10-Q · filed 2020-05-14 | -$0.54 10-Q · filed 2019-05-13 | -$8.61 derived: net income ÷ weighted average shares · filed 2020-05-14 | -$10.94 derived: net income ÷ weighted average shares · filed 2020-05-14 | -$13.77 derived: net income ÷ weighted average shares · filed 2020-05-14 | ||||
| 2018-12-31 | -$2.09 derived: net income ÷ weighted average shares · filed 2020-03-26 | -$4.40 derived: net income ÷ weighted average shares · filed 2020-03-26 | -$7.15 derived: net income ÷ weighted average shares · filed 2020-03-26 | -$9.66 10-K · filed 2020-03-26 | -$0.80 10-K · filed 2019-03-29 | ||||
| 2018-09-30 | -$2.31 10-Q · filed 2019-11-14 | -$0.19 10-Q · filed 2018-11-09 | -$5.07 derived: net income ÷ weighted average shares · filed 2019-11-14 | -$7.58 10-Q · filed 2019-11-14 | -$0.63 10-Q · filed 2018-11-09 | ||||
| 2018-06-30 | -$2.78 10-Q · filed 2019-08-14 | -$0.23 10-Q · filed 2018-08-10 | -$5.29 10-Q · filed 2019-08-14 | -$0.44 10-Q · filed 2018-08-10 | |||||
| 2018-03-31 | -$0.21 10-Q · filed 2019-05-13 | ||||||||
| 2017-12-31 | -$0.41 10-K · filed 2019-03-29 | ||||||||
| 2017-09-30 | -$0.26 10-Q · filed 2018-11-09 | -$0.93 10-Q · filed 2018-11-09 | |||||||
| 2017-06-30 | -$0.34 10-Q · filed 2018-08-10 | -$0.67 10-Q · filed 2018-08-10 | |||||||
| 2017-03-31 | -$0.34 10-Q · filed 2018-05-15 | ||||||||
| 2016-12-31 | -$7.84 10-K · filed 2018-03-30 | ||||||||
| 2016-09-30 | -$0.28 10-Q · filed 2017-11-14 | -$7.54 10-Q · filed 2017-11-14 | |||||||
| 2016-06-30 | -$6.12 10-Q · filed 2017-08-14 | -$8.28 10-Q · filed 2017-08-14 | |||||||
| 2016-03-31 | -$0.78 10-Q · filed 2017-05-15 | ||||||||
| 2015-12-31 | -$2.96 10-K · filed 2017-03-31 | -$0.09 10-K · filed 2016-03-30 | |||||||
| 2015-09-30 | -$1.26 10-Q · filed 2016-11-14 | -$0.04 10-Q · filed 2015-11-16 | -$2.10 10-Q · filed 2016-11-14 | -$0.06 10-Q · filed 2015-11-16 | |||||
| 2015-06-30 | -$0.27 10-Q · filed 2016-08-15 | -$0.01 10-Q · filed 2015-08-19 | -$0.84 10-Q · filed 2016-08-15 | -$0.03 10-Q · filed 2015-08-19 | |||||
| 2015-03-31 | -$0.02 10-Q · filed 2015-05-20 | ||||||||
| 2014-12-31 | -$0.11 10-K · filed 2016-03-30 | ||||||||
| 2014-09-30 | -$0.02 10-Q · filed 2015-11-16 | -$0.07 10-Q · filed 2015-11-16 | |||||||
| 2014-06-30 | -$0.02 10-Q · filed 2015-08-19 | -$0.05 10-Q · filed 2015-08-19 | |||||||
| 2014-03-31 | -$0.03 10-Q · filed 2015-05-20 | ||||||||
| 2013-12-31 | -$0.07 10-K · filed 2015-07-20 | ||||||||
| 2013-11-30 | $0.00 10-Q · filed 2014-01-10 | ||||||||
| 2013-09-30 | -$0.02 10-Q · filed 2014-11-14 | -$0.04 10-Q · filed 2014-11-14 | |||||||
| 2013-08-31 | $0.00 10-K · filed 2013-11-27 | ||||||||
| 2013-06-30 | -$0.01 10-Q · filed 2014-08-14 | -$0.02 10-Q · filed 2014-08-14 | |||||||
| 2013-05-31 | $0.00 10-Q · filed 2013-07-17 | $0.00 10-Q · filed 2013-07-17 | |||||||
| 2013-03-31 | -$0.01 10-Q · filed 2014-05-20 | ||||||||
| 2013-02-28 | $0.00 10-Q · filed 2013-04-22 | $0.00 10-Q · filed 2013-04-22 | |||||||
| 2012-12-31 | -$0.05 10-K · filed 2015-07-20 | ||||||||
| 2012-11-30 | -$0.00 10-Q · filed 2014-01-10 | -$0.01 10-Q · filed 2013-01-22 | |||||||
| 2012-08-31 | -$0.01 10-K · filed 2013-11-27 | ||||||||
| 2012-05-31 | $0.00 10-Q · filed 2013-07-17 | $0.00 10-Q · filed 2013-07-17 | -$0.01 10-Q · filed 2012-07-16 | ||||||
| 2012-02-29 | $0.00 10-Q · filed 2013-04-22 | $0.00 10-Q · filed 2013-04-22 | |||||||
| 2011-11-30 | $0.00 10-Q · filed 2013-01-22 | ||||||||
| 2011-08-31 | $0.00 10-K · filed 2012-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |